Facundo Davaro

#SLUrology graduate. SUO Fellow @MoffitNews. Married to a pathologist @EPDavaro. Father of three girls!

[Tom Powles @tompowles1]

The EMA has approved Enfortumab Vedotin and pembrolizumab for 1st line urothelial cancer. It supersedes 1st platinum based therapy as the new standard of care in Europe. https://t.co/vn4Tp2Racf

[Saint Louis University Urology Residency Program @SLUrology]

Come join us in St.Louis!!!

Clinical Faculty Academic Position: Genitourinary Reconstructive Urologist | SSM SLUCare Physician Group | St. Louis, Missouri https://t.co/TYQ4JU68QX

[Julio Pow-Sang @JulioPowSangMD]

Promising results with combination Oncolytic Adenovirus+Pembro in bladder cancer reported in @NatureMedicine by @UrogerliMD from @MoffittNews

[PaulCrispenMD @PaulCrispenMD]

Efficacy of BCG for non-muscle invasive bladder cancer following nephr... Hoping to discover improved treatment strategies to decrease bladder cancer recurrences after nephroureterectomy https://t.co/IqzA136CEZ

[Josh Linscott @jlinscott_uro]

Hard to believe @UroChrisGuske is only an MS2! Already doing great research with @MoffittGUOnc.

Really well received presentation on increased risk of progression for BCG unresponsive patients when there are delays in initiating BST.

#AUA2024

[Allison May, MD @may_alley]

This meant so much to me. Thankful to @AmerUrological , the judges and organizers for supporting early career investigators. And my mentors @UMichUrology @SLUrology. So much incredible research going on in the field of urology. I hope to live up to it @uvaurology!

[Moffitt Cancer Center @MoffittNews]

At #AUA24, Mitch Hayes, MD, (@MitchHayesMD) presents the latest research on renal cell carcinoma.
#CancerResearch @AmerUrological

[Amer. Urol. Assn. @AmerUrological]

The only session at #AUA24 completely dedicated to highlighting the work of early-career investigators is a can't-miss event! Join us on Sunday, May 5th, and see Presenters like @may_alley showcase their work!

Learn more and add to your schedule: https://t.co/6FtIMYUuZO

[Roger Li @UrogerliMD]

Work led by @pbandmurthy @MoffittGUOnc 👀 at ct & utDNA🧬prior to RC

Surprisingly difficult to use as staging tool, but significant increases in utDNA TF in CIS pts

@SpiessPhilippe @WadeJSexton9 @sgilbert1973 @gdgrass @xuefwang @JoshMeeks @AndreaNecchi @LiangChengMD @predicine

[Wade J Sexton @WadeJSexton9]

Many congratulations to @jlinscott_uro and to your 💯super mentor @UrogerliMD. @MoffittGUOnc @MoffittNews @SUO_YUO

[Heather Huelster @HHuelsterMD]

Collaborative effort to improve outcomes in UTUC by @MoffittNews @predicine is officially
online @EUplatinum!

Preop plasma ctDNA has 94% specificity for muscle-invasion or LN positivity at NephU ➡️ may help select optimal pts for NAC!

https://t.co/nWHdKkPn6I

Tweetorial 🔽

[Roger Li @UrogerliMD]

Our study is finally online @EUplatinum! https://t.co/V7z6XKH2gv…

▶️Pre-op plasma ctDNA predicts muscle invasive #UTUC on surgical specimen
▶️ctDNA prognostic of post-surgical outcomes

Amazing collaboration with @FaltasLab @AndreaNecchi @JoshMeeks @predicine @MoffittGUOnc

[Facundo Davaro @FDavaro]

Incredible course highlighting the value of focal therapy and the importance of patient selection with invaluable insight from leaders in the field. Thank you @cjweight @RubenOlivaresG @CleClinicUro @SUO_YUO

[Chris Weight @cjweight]

Just concluded the first ever @UroOnc @CleClinicUro @SUO_YUO focal therapy course in #ProstateCancer with @RubenOlivaresG

Great success with fellows from all over North America!

[Saint Louis University Urology Residency Program @SLUrology]

What an incredible weekend at #SCS2023!! Huge shoutout to our medical students for all their hard work with their research projects

[Wei Shen Tan @drtanws]

Pooling together patients from @MDAndersonNews @MoffittNews @uiowa we report outcomes of IR-NMIBC patients treated with Gem-Doce vs BCG in @EurUrolOncol

@IanMcelree @FDavaro @ryansteinbergmd @KKBree @nnavai #ColinDinney #MikeODonnell @UrogerliMD @UroDocAsh @VigneshPackiam

[Philippe spiess @SpiessPhilippe]

The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features - ScienceDirect https://t.co/YGQozQ4MAq

[UroToday.com @urotoday]

The importance of surgical margin and extent of lymphadenectomy on clinical outcomes in patients with plasmacytoid #UrothelialCarcinoma. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses work by @FDavaro et al. in @UrolOncol > https://t.co/JomB21BWWO @UrogerliMD @EPDavaro

[UCSD Urology @UCSD_Urology]

UCSD is recruiting motivated SUO applicants for accredited fellowship position starting 8-2024! Come join our dynamic team @JuanDeslogesMD @AdityaBagrodia @AmirSalmasi @Cold_Steel_1970 @DrRanaMcKay @TylerSbrt @DrTylerStewart

[Wade J Sexton @WadeJSexton9]

Grateful to @AChangUro @HHuelsterMD @KyleRoseMD for choosing @MoffittGUOnc for @UroOnc fellowship training. You 💯epitomize compassion, skill, and excellence! Simply amazing. Will miss you!
@MoffittNews @OchsnerUrology @IUuro @DukeUroRes @VUMCurology @MayoUrology

[Sarah P. Psutka MD MS @spsutkaMD]

Hey @UroOnc! Don't forget to tune in with me and @UrogerliMD at 6p CST tomorrow night (6/12/2023) for our #ASCO2023 Recap w/ presentations from @slernerbcmedu1 @BraunMDPhD @AdityaBagrodia & Dr. Karen Hoffman. You don't want to miss this! Register here: https://t.co/pdwbtOV8BJ